1.400038 重庆,陆军军医大学(第三军医大学)第一附属医院神经外科
2.400038 重庆,陆军军医大学(第三军医大学)第一附属医院神经内科
3.614000 四川 乐山,武警四川省总队医院神经外科
Received:24 February 2022,
Revised:2022-03-16,
Published:30 May 2022
移动端阅览
Chengming LING, Weihua CHU, Jichao YUAN, et al. Cannabinoid receptor 2 agonist AM1241 inhibits fibrous scarring after spinal cord injury in rats[J]. Journal of Army Medical University, 2022, 44(10): 991-1000.
Chengming LING, Weihua CHU, Jichao YUAN, et al. Cannabinoid receptor 2 agonist AM1241 inhibits fibrous scarring after spinal cord injury in rats[J]. Journal of Army Medical University, 2022, 44(10): 991-1000. DOI: 10.16016/j.2097-0927.202202141.
目的
2
探讨AM1241对大鼠脊髓损伤后纤维瘢痕形成的作用及其机制。
方法
2
选取雌性6~8周龄Sprague-Dawley大鼠144只,分为4组:①假手术组(
n
=24)只移除椎板以暴露硬脊膜,不切开硬脊膜,术后给予生理盐水3 mL/kg;②载体组(
n
=40)建立大鼠脊髓背侧半切损伤模型,术后给予生理盐水3 mL/kg;③AM1241组(
n
=40)在载体组基础上给予大麻素受体2(cannabinoid receptor 2,CBR2)激动剂(AM1241,3 mg/kg) 治疗;④AM1241+AM630组(
n
=40)在术后AM1241治疗前30 min给予CBR2拮抗剂(AM630,3 mg/kg)。各组药物均腹腔注射,1次/d,连续14 d。采用免疫荧光染色、Western blot、ELISA等方法评估AM1241对大鼠纤维瘢痕形成的抑制作用,同时采用行为学、电生理检测AM1241对大鼠神经功能的影响。
结果
2
与载体组比较,AM1241组大鼠脊髓损伤后,主要纤维瘢痕成分的表达降低,脊髓损伤后,纤维瘢痕面积减少,给予CBR2拮抗剂AM630后逆转了上述现象,差异均有统计学意义(
P
<
0.05)。tubulin βⅢ免疫荧光染色、行为学评估、电生理实验结果显示:AM1241组促进了脊髓神经元细胞的存活,改善了脊髓损伤后的神经功能,包括Basso-Beattie-Bresnahan(BBB)评分[载体组(15.38±0.38)
vs
AM1241组(18.38±0.50)
vs
AM1241+AM630组(15.50±0.33),
P
<
0.05
]
、斜板实验角度[载体组(54.25±1.25)°
vs
AM1241组(64.25±1.05)°
vs
AM1241+AM630组(54.75±0.49)°,
P
<
0.05
]
等;ELISA实验结果显示:AM1241组抑制M1型巨噬细胞标记物iNOS、TNF-α、IL-1β的表达(
P
<
0.05),增强M2型巨噬细胞标记物CD206、Arg-1的表达(
P
<
0.05),降低促纤维化因子TGF-β1的表达(
P
<
0.01);而应用CBR2拮抗剂AM630后逆转了上述作用。
结论
2
刺激大鼠CBR2能减少脊髓损伤后纤维瘢痕、改善神经功能,这一作用可能是通过影响巨噬细胞极化来实现的。
Objective
2
To determine the role of cannabinoid receptor 2 (CBR2) agonist
AM1241
in the formation of fibrous scars in rats after spinal cord injury and elucidate the underlying mechanism.
Methods
2
A total of 144 female Sprague-Dawley rats were selected an
d divided into 4 groups: sham operation group (
n
=24
only the lamina was removed to expose the dura mater
and 3 mL/kg normal saline was given postoperatively)
vehicle group (
n
=40
the rats was inflicted to establish a model of dorsal hemisection and then given 3 mL/kg of normal saline)
AM1241 group (
n
=40
the rats were given 3 mg/kg AM1241 on the basis of the vehicle group)
and AM1241+AM630 group (
n
=40
after modeling
the rats were given 3 mg/kg AM630
CBR2 antagonist
in 30 min before AM1241 treatment). The corresponding drugs were injected intraperitoneally to each group
once a day
for 14 consecutive days. Immunofluorescence staining
Western blotting and ELISA were performed to evaluate the inhibitory effects of AM1241 on fibrous scar formation
and behavioral electrophysiology were carried out to detect its effect on neurological function.
Results
2
After spinal cord injury
AM1241 significantly reduced the expression of the main molecules in fibrous scars
as well as the area of fibrous scar
while the treatment of AM630 reversed above phenomena
with statistical significances (
P
<
0.05). The results of tubulin βⅢ immunofluorescence staining
behavioral assessment as well as electrophysiological experiments demonstrated that AM1241 could promote the survival of spinal cord neurons
improve neurological function after injury
such as Basso-Beattie-Bresnahan(BBB) score and angle of oblique board test [vehicle group
vs
AM1241 group
vs
AM1241+AM630 group: 15.38±0.38
vs
18.38± 0.50
vs
15.50±0.33
P
<
0.05; (54.25±1.25)°
vs
(64.25±1.05)°
vs
(54.75±0.49)°
P
<
0.05
]
. ELISA indicated that AM1241 inhibited the expression of iNOS
TNF-α and IL-1β (markers of M1-type macrophages
P
<
0.01)
enhanced the expression of CD206 and Arg-1 (ma
rkers of M2-type macrophages
P
<
0.05)
and decreased the expression of TGF-β1 (fibrogenic factor
P
<
0.01). The treatment of CBR2 antagonist
AM630 led to opposite results.
Conclusion
2
Stimulation of CBR2 decreases fibrous scarring and improves neurological function after spinal cord injury in rats
which might be attained by influencing macrophage polarization.
ANAND U, OTTO W R, SANCHEZ-HERRERA D, et al . Cannabinoid receptor CB 2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons[J ] . Pain, 2008, 138(3): 667-680. DOI: 10.1016/j.pain.2008.06.007..
CORREIA-SÁ I, PAIVA A, CARVALHO C M, et al . Cutaneous endocannabinoid system: does it have a role on skin wound healing bearing fibrosis?[J ] . Pharmacol Res, 2020, 159: 104862. DOI: 10.1016/j.phrs.2020.104862.
LI X, HAN D, TIAN Z H, et al . Activation of cannabinoid receptor type Ⅱ by AM1241 ameliorates myocardial fibrosis via Nrf2-mediated inhibition of TGF-β1/Smad3 pathway in myocardial infarction mice[J ] . Cell Physiol Biochem, 2016, 39(4): 1521-1536. DOI: 10.1159/000447855.
ZHOU L L, ZHOU S, YANG P, et al . Targeted inhibition of the type 2 cannabinoid receptor is a novel approach to reduce renal fibrosis[J ] . Kidney Int, 2018, 94(4): 756-772. DOI: 10.1016/j.kint.2018.05.023.
PARLAR A, ARSLAN S O, YUMRUTAS O, et al . Effects of cannabinoid receptor 2 synthetic agonist, AM1241, on bleomycin induced pulmonary fibrosis[J ] . Biotech Histochem, 2021, 96(1): 48-59. DOI: 10.1080/10520295.2020.1758343.
YU S J, REINER D, SHEN H, et al . Time-dependent protection of CB 2 receptor agonist in stroke[J ] . PLoS One, 2015, 10(7): e0132487. DOI: 10.1371/journal.pone.0132487..
ZHANG M Y, DONG L L, ZOU H C, et al . Effects of cannabinoid type 2 receptor agonist AM1241 on morphine-induced antinociception, acute and chronic tolerance, and dependence in mice[J ] . J Pain, 2018, 19(10): 1113-1129. DOI: 10.1016/j.jpain.2018.04.009.
YUAN J C, LIU W, ZHU H T, et al . Curcumin inhibits glial scar formation by suppressing astrocyte-induced inflammation and fibrosis in vitro and in vivo [J ] . Brain Res, 2017, 1655: 90-103. DOI: 10.1016/j.brainres.2016.11.002..
WANJIANG W, XIN C, YAXING C, et al . Curcumin improves human umbilical cord-derived mesenchymal stem cell survival via ERK1/2 signaling and promotes motor outcomes after spinal cord injury[J ] . Cell Mol Neurobiol, 2020: 2020Nov27. DOI: 10.1007/s10571-020-0101 8-7.
YUAN J C, ZOU M M, XIANG X, et al . Curcumin improves neural function after spinal cord injury by the jointinhibition of the intracellular and extracellular components of glial scar[J ] . J Surg Res, 2015, 195(1): 235-245. DOI: 10.1016/j.jss.2014.12.055.
向鑫, 袁继超, 陈飞, 等. 姜黄素诱导内源性神经干细胞促进大鼠脊髓损伤后功能修复[J]. 第三军医大学学报, 2014, 36(9): 883-887. DOI: 10.16016/j.1000-5404.2014.09.017.
XIANG X, YUAN J C, CHEN F, et al . Curcumin induces endogenous neural stem cells to promote functional recovery in rats after spinal cord injury[J ] . J Third Mil Med Univ, 2014, 36(9): 883-887. DOI: 10.16016/j.1000-5404.2014.09.017.
XIE C Z, LI X Z, FANG L, et al . Effects of athermal shortwave diathermy treatment on somatosensory evoked potentials and motor evoked potentials in rats with spinal cord injury[J ] . Spine (Phila Pa 1976), 2019, 44(13): E749-E758. DOI: 10.1097/BRS.0000000000002980.
廖小俊, 袁继超, 朱海涛, 等. 莱菔硫烷对小鼠脊髓损伤后后肢功能的作用[J]. 第三军医大学学报, 2016, 38(10): 1066-1072. DOI: 10.16016/j.1000-5404.201511182.
LIAO X J, YUAN J C, ZHU H T, et al . Effect of sulforaphane on hindlimb function after spinal cord injury in mice[J ] . J Third Mil Med Univ, 201 6, 38(10): 1066-1072. DOI: 10.16016/j.1000-5404.201511182.
DIAS D O, KIM H, HOLL D, et al . Reducing pericyte-derived scarring promotes recovery after spinal cord injury[J ] . Cell, 2018, 173(1): 153-165.e22. DOI: 10.1016/j.cell.2018.02.004.
ANDERSON M A, BURDA J E, REN Y L, et al . Astrocyte scar formation aids central nervous system axon regeneration[J ] . Nature, 2016, 532(7598): 195-200. DOI: 10.1038/nature17623.
HELLAL F, HURTADO A, RUSCHEL J, et al . Micro-tubule stabilization reduces scarring and causes axon regeneration after spinal cord injury[J ] . Science, 2011, 331(6019): 928-931. DOI: 10.1126/science.1201148.
POOYANIA S, ETHANS K, SZTURM T, et al . A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury[J ] . Arch Phys Med Rehabil, 2010, 91(5): 703-707. DOI: 10.1016/j.apmr.2009.12.025.
ZHANG J, HOFFERT C, VU H K, et al . Induction of CB 2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models[J ] . Eur J N eurosci, 2003, 17(12): 2750-2754. DOI: 10.1046/j.1460-9568.2003.02704.x..
BAHR B A, KARANIAN D A, MAKANJI S S, et al . Targeting the endocannabinoid system in treating brain disorders[J ] . Expert Opin Investig Drugs, 2006, 15(4): 351-365. DOI: 10.1517/13543784.15.4.351.
LAPRAIRIE R B, KELLY M E M, DENOVAN-WRIGHT E M. The dynamic nature of type 1 cannabinoid receptor[CB(1)]gene transcription[J]. Br J Pharmacol, 2012, 167(8): 1583-1595. DOI: 10.1111/j.1476-5381.2012.02175.x.
TALAMONTI E, PAUTER A M, ASADI A, et al . Impairment of systemic DHA synthesis affects macrophage plasticity and polarization: implications for DHA supplementation during inflammation[J ] . Cell Mol Life Sci, 2017, 74(15): 2815-2826. DOI: 10.1007/s00018-017-2498-9.
CITRON B A, ARNOLD P M, SEBASTIAN C, et al . Rapid upregulation of caspase-3 in rat spinal cord after injury: mRNA, protein, and cellular localization correlates with apoptotic cell death[J ] . Exp Neurol, 2000, 166(2): 213-226. DOI: 10.1006/exnr.2000.7523.
ETZERODT A, MOESTRUP S K. CD163 and inflammation: biological, diagnostic, and therapeutic aspects[J]. Antioxid Redox Signal, 2013, 18(17): 2352-2363. DOI: 10.1089/ars.2012.4834.
YANG R L, HE J Y, WANG Y L. Activation of the niacin receptor HCA 2 reduces demyelination and neurofilament loss, and promotes functional recovery after spinal cord injury in mice[J ] . Eur J Pharmacol, 2016, 791: 124-136. DOI: 10.1016/j.ejphar.2016.08.020.
LIU G, FRIGGERI A, YANG Y P, et al . miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis[J ] . J Exp Med, 2010, 207(8): 1589-1597. DOI: 10.1084/jem.20100035.
FUNK L H, HACKETT A R, BUNGE M B, et al . Tumor necrosis factor superfamily member APRIL contributes to fibrotic scar formation after spinal cord injury[J ] . J Neuroinflamm, 2016, 13(1): 87. DOI: 10.1186/s12974-016-0552-4.
SODERBLOM C, LUO X T, BLUMENTHAL E, et al . Perivascular fibroblasts form the fibrotic scar after contusive spinal cord injury[J ] . J Neurosci, 2013, 33(34): 13882-13887. DOI: 10.1523/JNEUROSCI.2524-13.2013.
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
